Just a moment...

Top
Help
AI Drafter

Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.

Step 1 – Issue Identification & Review

The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.

• Review the issues identified by the AI
• Add, edit, remove, or refine issues as required


Step 2 – Draft Generation

Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.

• Relevant statutory provisions
• Judicial precedents and Supreme Court, High Court and other citations
• Issue-wise legal analysis
• Practical arguments and supporting content
• Professionally structured draft ready for further review.

Try Now
×

By creating an account you can:

Logo TaxTMI
>
Call Us / Help / Feedback

Contact Us At :

E-mail: [email protected]

Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
TMI Blog
Home / RSS

CCI approves proposed transaction involving sale of global biosimilars portfolio of Viatris Inc. to Biocon Biologics Limited and an equity infusion in Biocon Biologics by Biocon and Serum

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....CI approves proposed transaction involving sale of global biosimilars portfolio of Viatris Inc. to Biocon Biologics Limited and an equity infusion in Biocon Biologics by Biocon and Serum <br>News and Press Release<br>Dated:- 14-6-2022<br><BR>The Competition Commission of India (CCI) approves proposed transaction involving the sale of the global biosimilars portfolio of Viatris Inc. to Biocon Biolo....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....gics Limited (Biocon Biologics) and an equity infusion in Biocon Biologics by Biocon and Serum (Proposed Transaction). The Proposed Transaction involves the sale of the global biosimilars portfolio of Viatris Inc. (Viatris) (the indirect parent entity of Mylan Inc (Mylan) to Biocon Biologics and its subsidiary for cash and stock consideration and acquisition of 1 (one) common equity share and com....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....pulsory convertible preference shares convertible into common equity shares, representing at least 12.9% of the fully diluted equity of Biocon Biologics by Mylan (an indirect subsidiary of Viatris) as part consideration for the acquisition of the global biosimilars portfolio of Viatris, in each case, pursuant to the transaction agreement dated February 27th , 2022 entered into between Viatris and ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....Biocon Biologics. Mylan - Mylan is a Pennsylvania corporation and an indirect wholly owned subsidiary of Viatris. Viatris is a global pharmaceutical company, headquartered in Canonsburg, Pennsylvania, focused on bringing high quality medicines to patients in over 165 countries and territories. It offers a variety of medicines, including brands, generics and biosimilars, and over-the-counter produ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....cts across the world. Biocon Biologics - Biocon Biologics is a company limited by shares, incorporated in India. Biocon Biologics is a subsidiary of Biocon with a focus on Biocon's biosimilars business. Biocon Biologics is engaged in the manufacturing and commercialization of pharmaceutical formulations such as biosimilars, insulins and drug substances in India. Within India, Biocon Biologics als....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....o has a branded formulation business which is responsible for direct B2C sales. Serum Institute Life Sciences Private Limited (Serum) - Serum is an Indian private limited company and a subsidiary of Serum Institute of India Private Limited. Detailed order of the CCI will follow.<BR> News - Press release - PIB....